Despite the theoretical risk of GH therapy worsening contractures, data from the National Cooperative Growth Study indicate that only a small proportion (0.1%) of patients with idiopathic short stature receiving GH reported arthralgia or arthritis (10). Here, GH1 is linked to arthritic joint disease.